These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38134944)

  • 41. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quarterly versus annual ECG screening for atrial fibrillation in older Chinese individuals (AF-CATCH): a prospective, randomised controlled trial.
    Zhang W; Chen Y; Miao CY; Huang QF; Sheng CS; Shao S; Wang D; Xu SK; Lei L; Zhang D; Chen YL; Hu LX; Xia JH; Ye XF; Cheng YB; Wang Y; Guo QH; Li Y; Lowres N; Freedman B; Wang JG;
    Lancet Healthy Longev; 2021 Aug; 2(8):e470-e478. PubMed ID: 36097996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.
    Koehler F; Koehler K; Deckwart O; Prescher S; Wegscheider K; Kirwan BA; Winkler S; Vettorazzi E; Bruch L; Oeff M; Zugck C; Doerr G; Naegele H; Störk S; Butter C; Sechtem U; Angermann C; Gola G; Prondzinsky R; Edelmann F; Spethmann S; Schellong SM; Schulze PC; Bauersachs J; Wellge B; Schoebel C; Tajsic M; Dreger H; Anker SD; Stangl K
    Lancet; 2018 Sep; 392(10152):1047-1057. PubMed ID: 30153985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in patients with COPD, asthma, diabetes mellitus type 2 and heart failure: protocol for a pragmatic clustered quasi-experimental study.
    Boudewijns EA; Claessens D; Joore M; Keijsers LCEM; van Schayck OCP; Winkens B; Gidding-Slok AHM
    BMJ Open; 2020 Nov; 10(11):e037693. PubMed ID: 33203626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    Kirchhof P; Camm AJ; Goette A; Brandes A; Eckardt L; Elvan A; Fetsch T; van Gelder IC; Haase D; Haegeli LM; Hamann F; Heidbüchel H; Hindricks G; Kautzner J; Kuck KH; Mont L; Ng GA; Rekosz J; Schoen N; Schotten U; Suling A; Taggeselle J; Themistoclakis S; Vettorazzi E; Vardas P; Wegscheider K; Willems S; Crijns HJGM; Breithardt G;
    N Engl J Med; 2020 Oct; 383(14):1305-1316. PubMed ID: 32865375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cluster-randomized study to evaluate the effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in South Tyrolean primary care for patients with COPD, asthma, type 2 diabetes, and heart failure: the ABCC South Tyrol study.
    Wiedermann CJ; Marino P; Mahlknecht A; Barbieri V; Piccoliori G; Engl A; Gidding-Slok AHM
    Trials; 2024 Mar; 25(1):202. PubMed ID: 38509576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
    Durheim MT; Holmes DN; Blanco RG; Allen LA; Chan PS; Freeman JV; Fonarow GC; Go AS; Hylek EM; Mahaffey KW; Pokorney SD; Reiffel JA; Singer DE; Peterson ED; Piccini JP
    Heart; 2018 Nov; 104(22):1850-1858. PubMed ID: 29875139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial.
    Moll van Charante EP; Richard E; Eurelings LS; van Dalen JW; Ligthart SA; van Bussel EF; Hoevenaar-Blom MP; Vermeulen M; van Gool WA
    Lancet; 2016 Aug; 388(10046):797-805. PubMed ID: 27474376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
    Ueki K; Sasako T; Okazaki Y; Kato M; Okahata S; Katsuyama H; Haraguchi M; Morita A; Ohashi K; Hara K; Morise A; Izumi K; Ishizuka N; Ohashi Y; Noda M; Kadowaki T;
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):951-964. PubMed ID: 29079252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial.
    Abraham WT; Stevenson LW; Bourge RC; Lindenfeld JA; Bauman JG; Adamson PB;
    Lancet; 2016 Jan; 387(10017):453-61. PubMed ID: 26560249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity: The mAFA-II Randomized Clinical Trial.
    Yao Y; Guo Y; Lip GYH;
    JAMA Netw Open; 2021 Dec; 4(12):e2140071. PubMed ID: 34932104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial.
    Gilbody S; Peckham E; Bailey D; Arundel C; Heron P; Crosland S; Fairhurst C; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C
    Lancet Psychiatry; 2019 May; 6(5):379-390. PubMed ID: 30975539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
    Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lindenfeld J; Zile MR; Desai AS; Bhatt K; Ducharme A; Horstmanshof D; Krim SR; Maisel A; Mehra MR; Paul S; Sears SF; Sauer AJ; Smart F; Zughaib M; Castaneda P; Kelly J; Johnson N; Sood P; Ginn G; Henderson J; Adamson PB; Costanzo MR
    Lancet; 2021 Sep; 398(10304):991-1001. PubMed ID: 34461042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular disease risk in real life: a randomized controlled trial.
    Lakerveld J; Bot SD; Chinapaw MJ; van Tulder MW; Kostense PJ; Dekker JM; Nijpels G
    Int J Behav Nutr Phys Act; 2013 Apr; 10():47. PubMed ID: 23597082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical Trial.
    Infeld M; Wahlberg K; Cicero J; Plante TB; Meagher S; Novelli A; Habel N; Krishnan AM; Silverman DN; LeWinter MM; Lustgarten DL; Meyer M
    JAMA Cardiol; 2023 Mar; 8(3):213-221. PubMed ID: 36723919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice - the ECSTATIC study: a cluster randomised non-inferiority trial.
    Luymes CH; Poortvliet RKE; van Geloven N; de Waal MWM; Drewes YM; Blom JW; Smidt N; Assendelft WJJ; van den Hout WB; de Ruijter W; Numans ME
    BMC Med; 2018 Jan; 16(1):5. PubMed ID: 29321031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.